Finnish healthtech Treat raises €3M to tackle inefficiencies in private healthcare
What happened
Healthtech company Treat has raised a €3 million pre-seed round (an early stage of company funding) led by early Lovable backer byFounders and Supercell founder Ilkka Paananen’s Illusian . Healthtech Backed by byFounders and Illusian, Treat combines AI-powered patient intake with doctor-led consultations to reduce unnecessary appointments and improve access to care.
Treat connects patients in minutes with doctors who are already briefed on their medical background, eliminating unnecessary appointments and misaligned incentives in private care.
Why private healthcare profits from inefficiency Private healthcare is built on volume: clinics profit from the number of appointments and follow-ups. The system leaves doctors with no time to review medical histories and patients caught in diagnostic ping-pong.
AI for intake, humans for medicine Treat applies AI strictly to eliminate administrative drag. Patients describe symptoms in their own words, and an adaptive intake tool gathers relevant context into an organised brief.
No patient records or identifiable data touch public LLMs, and licensed physicians retain exclusive access to medical history and make all clinical decisions. Treat is offered to employees through their employers, complementing existing private health insurance and occupational healthcare.